Eli Lilly’s Zepbound proved more effective than Novo Nordisk’s Wegovy in a new head-to-head trial, though both medications ...

Key research pitching the drugs against each other found Mounjaro was superior when it came to shedding pounds and losing ...

Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...

Weight loss jabs combined with lifestyle choices can be a gamechanger for those stuck in the cycle of yo-yo-dieting.

In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly. Participants who received tirzepatide also had greater improvements in metabolic risk ...

Weight-loss jab Mounjaro helps people shed significantly more weight than rival Wegovy, new research suggests.

A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...

A trial was conducted comparing weight loss medications Zepbound and Wegovy. Results from the trial found that participants ...

A major UK study has revealed that older women are getting the best results from weight loss jabs – not from shortcuts, but ...